EGFR and hepatocellular carcinoma: Notably, in the β‐catenin positive HCC model, pathways such as oxidative phosphorylation emerged as highly enriched, while pathways associated with cancer (such as HCC, ErbB, and IL‐17 signaling pathways) were downregulated.